Visceral fat accumulation plays an important role in the occurrence of coronary artery disease (CAD) associated with a cluster of multiple risk factors, such as glucose intolerance, insulin resistance and hyperlipoproteinemia. To clarify the detailed features of these factors, based on visceral fat accumulation, the present study examined the relationship between fat distribution and the characteristics of glucose metabolism and serum lipoproteins in middle-aged non-obese Japanese men. First, the influence of visceral fat accumulation on glucose metabolism, insulin sensitivity, and the extent and severity of coronary artery lesions was investigated in 50 subjects with CAD and compared with 15 control subjects without CAD (Study 1) and with the lipoprotein characteristics in 44 subjects without CAD who were not treated with lipid-lowering drugs (Study 2). Body fat distribution was determined by abdominal computed tomography. In Study 1, the visceral fat area (VFA), blood pressure, fasting immunoreactive insulin (FIRI), and the plasma insulin area (PIA) obtained by oral glucose tolerance test in the subjects with CAD were all significantly higher than in the control subjects. The VFA was significantly correlated with FIRI, the homeostasis model of insulin resistance, PIA and steady state plasma glucose (SSPG) concentration as an index for insulin resistance (r=0.57, p<0.001, r=0.49, p<0.01, r=0.36, p<0.01, and r=0.50, p<0.05, respectively). Although the SSPG concentration did not correlate with the coronary atherosclerosis index as a score of the extent and severity of coronary lesions, the VFA was significantly correlated with this index (r=0.43, p<0.01). In Study 2, the VFA had significant positive correlations with serum total cholesterol, triglyceride, and apolipoprotein B and E levels and the cholesterol and triglyceride concentrations of very-low-density lipoprotein, intermediate-density lipoprotein, and low-density lipoprotein (LDL) fractions. There was a negative correlation between the VFA and LDL particle size (r=-0.34, p<0.05). In conclusion, visceral fat accumulation may contribute to the development of CAD through the progression of insulin resistance and the increase of apo Bcontaining lipoproteins and small-sized LDLs in middle-aged non-obese Japanese men. (Jpn Circ J 2001; 65: 193 -199) particle size to characterize the lipoprotein profiles in nonobese subjects with visceral fat accumulation.
Methods

Body Fat Distribution
Body fat distribution was determined by computed tomographic (CT) scanning (General Electric CT/T scanner, General Electric Co, Milwaukee, WI, USA) in the supine position according to our previously described procedure. 18 The fat layer of the extraperitoneal region between the skin and muscle was defined as the subcutaneous fat area (SFA), with an attenuation range from -40 to -140 Hounsfield units (HU). The intraperitoneal region, with the same density as the SFA, was defined as the visceral fat area (VFA). The SFA and the VFA were measured at the level of the umbilicus.
Visceral Fat Accumulation and Glucose Metabolism, Insulin Sensitivity, and Coronary Artery Disease (Study 1)
We investigated the occurrence of coronary artery lesions in 65 hospitalized male subjects aged 55±10 years (range, 40-69 years) by coronary arteriography from 1994 to 1997. The presence of CAD was suspected on the basis of symptoms and/or the results of exercise tolerance tests and there were 50 subjects who had evidence of coronary artery stenoses, with at least 1 lesion occluding 25% or more of the diameter of the coronary segments; the remaining 15 subjects did not have any coronary artery lesions and constituted the control group. In the patients with coronary artery stenoses, 17 had a history of myocardial infarction (MI) (antero-septal MI, 8; lateral MI, 1; inferior MI; 8), 24 patients had effort angina pectoris, 7 had vasospastic angina, and 2 did not have cardiac symptoms with significant coronary stenoses (silent myocardial ischemia). Of the 50 patients with CAD, 46 had angiographically significant lesions with greater than 50% stenosis (11 with 3-vessel disease, 14 with 2-vessel disease, 21 with 1-vessel disease) and the remaining 4 patients had coronary lesions with 50% stenosis. The 15 control subjects with angiographically normal coronary arteries underwent cardiac catheterization because of atypical chest pain (9), vasospastic angina (4), suspected cardiomyopathy (1), and aortic valve disease (1) . To exclude the influence of aging and obesity, the subjects who were obese with a body mass index (BMI) over 120% of the standard value of 22 (>BMI of 26.4), 19 and those who were either under 40 years or over 70 years of age were excluded. Patients with familial hypercholesterolemia or with diabetes mellitus treated by insulin were also excluded. All of the subjects gave their informed consent before entering the study.
Blood samples were drawn after more than 12 h of fasting and total cholesterol (TC) and triglyceride (TG) concentrations were measured enzymatically using commercial kits (Kyowa Medex, Tokyo, Japan) and HDL-cholesterol was quantified by the heparin-Ca 2+ precipitation method. 20 Fasting plasma glucose (FPG) and fasting immunoreactive insulin (FIRI) were measured by the glucose oxidase method and double antibody radioimmunoassay, respectively. We use the homeostasis model of insulin resistance (HOMA-IR) as a measure of insulin resistance. The formula for the HOMA-IR is (FIRI (pmol/L) × FPG (mmol/L)) / 135. 21 The oral glucose tolerance test (OGTT) was performed in all of the subjects using a 75-g dose of glucose. The glucose and insulin concentrations were measured at 0, 30, 60, 90, and 120 min and the plasma glucose area (PGA) and plasma insulin area (PIA) were calculated from the sum of the trapezoid areas under the glucose or immunoreactive insulin concentrations' curve. 12 Blood pressure (BP) was taken from the right arm using a mercury sphygmomanometer, after the subjects had rested in a sitting position for 15 min. The diastolic BP was recorded when Korotkoff sounds disappeared (phase 5).
Steady State Plasma Glucose (SSPG)
The SSPG concentration was measured in 25 patients admitted from 1995 to 1997 in order to evaluate the relationship between insulin sensitivity and abdominal fat distribution. It was obtained by the method of Mimura et al 22 after an overnight fast, intravenous catheters were placed in both arms. Blood was drawn from one arm for measuring plasma glucose and insulin concentrations, and the other arm was used for the administration of test substances. Sandstatin ® , a somatostatin analogue, was administered at the dose of 30 g/h to suppress endogenous insulin secretion and simultaneously, insulin and glucose were infused at 2 mU· kg -1 · min -1 and 9mg·kg -1 ·min -1 , respectively. Blood was sampled hourly for 2 h, then every 10 min at 150, 160, 170, and 180 min. The averaged glucose level of 4 samples obtained from 150 to 180 min was defined as the SSPG concentration.
Coronary Arteriography and Scoring of Coronary Angiogram
Coronary arteriography was performed by the standard Judkins' technique and evaluated independently by 3 trained investigators without any knowledge of the subjects' clinical history and data. The extent and severity of coronary stenotic lesions were assessed by assigning scores to each of the 15 segments according to the classification of the American Heart Association Grading Committee. The coronary atherosclerosis index (CAI) was defined as the sum of the scores of these segments. 23, 24 Stenosis of less than 25% was graded as 1, 25-49% stenosis as 2, 50-74% stenosis as 3, and more than 75% stenosis as 4. Thus, the highest possible score was 60.
Visceral Fat Accumulation and Lipid Metabolism (Study 2)
To evaluate the influence of visceral fat accumulation on lipid metabolism in non-obese subjects, 44 selected male subjects aged 55±10 years (range, 31-69 years) with an average BMI value of 24.1±1.6 and who were not taking drugs that would affect lipid metabolism consented to the study. Venous blood sample was drawn after an overnight fast and very low-density lipoprotein (VLDL), intermediate density lipoprotein (IDL), LDL, HDL2 and HDL3 were isolated by sequential preparative ultracentrifugation at densities 1.006, 1.019, 1.063, 1.125, and 1.210 g/ml, respectively. 25 TC and TG concentrations were measured enzymatically in the serum and every lipoprotein fraction. HDL-cholesterol was quantified by the heparin-Ca 2+ precipitation method. 20 Apolipoprotein (apo) concentrations were measured in the serum (apo A-I, B, and E) and LDL fraction (apo B) by an immunoturbidimetric method. We analyzed LDL particle size by high-performance liquid chromatography (HPLC) according to the modified method of Hara and Okazaki. 26 Unconcentrated conditioned medium (5 l) was applied to an HPLC system with 2 connected columns (TSK gel Lipopropak XL, 7.5 mm I. D. ×300 mm, Tosoh Co, Tokyo, Japan) and lipoproteins were separated by an eluent (TSK eluent LP-1, Tosoh Co) at a flow rate of 0.60 ml/min and at 25±2°C. The LDL particle size was determined with the flow time of the LDL peak from the HPLC starting time standardized by the flow time of albumin expressed with arbitrary units.
Statistics
Results were expressed as the mean values ± the standard deviation (SD). Group differences were compared by Student's non-paired t test. Comparison of several values (diastolic BP, serum TG, FIRI, and PIA), which were not normally distributed, were performed by the Mann-Whitney test. Simple correlation analyses were performed to determine which of the above measurements were associated with one another. Furthermore, partial correlation coefficients were calculated to assess the independent association for the parameters with significant simple correlation coefficients.
Results
Study 1
We investigated the relationship of visceral fat accumulation with glucose metabolism, insulin sensitivity, and the extent and severity of coronary artery lesions. Table 1 compares the clinical characteristics and laboratory findings of the patients with CAD and those of the control subjects. Age, BMI, and smoking habit were not significantly different between the 2 groups. VFA in the patients with CAD was significantly greater than in the control subjects, whereas SFA did not differ between the groups. The systolic and diastolic BP, FIRI, and PIA obtained by OGTT were significantly higher in the patients, whereas HDL-cholesterol was lower than in the control subjects. Mean CAI was 16.3 in the patients with CAD.
We evaluated the correlation between glucose metabolism and various clinical parameters in the subjects (Table 2) . There was a significant correlation between age and FIRI. BMI was significantly correlated with FPG, FIRI and HOMA-IR. VFA was significantly correlated with FIRI, HOMA-IR and PIA. There were no significant correlations between SFA and these variables.
We investigated insulin sensitivity estimated by the SSPG method in 25 patients and evaluated the correlation between the SSPG concentration and the other variables ( Table 3 ). The SSPG concentration was significantly correlated with VFA, systolic BP, and PGA. In the partial correlation analyses, the correlation between the VFA and the SSPG concentration remained significant, but the other correlations did not persist. Table 4 shows the simple correlation coefficients between CAI and the clinical and metabolic variables in all of the patients with CAD and in the patients in whom we estimated insulin sensitivity by the SSPG method. There was a significant correlation between VFA, FIRI, FPG, and HOMA-IR and CAI in all the patients. In the partial correlation analysis, only the correlation between VFA and CAI remained significant. In the subjects who were investigated by the SSPG method, VFA and the PGA had significant positive correlations with the CAI, and HDL-cholesterol had a negative correlation with this index. VFA also had a significant partial correlation with CAI, but the other 2 variables did not show any correlation.
Study 2
We investigated the influence of visceral fat accumulation on lipid metabolism in non-obese subjects. Simple correlation coefficients between clinical variables, lipid and apolipoprotein levels and lipid concentrations in the lipoprotein fractions in these subjects are shown in Table 5 . There was a positive correlation between age and the apo B level. BMI was negatively correlated with HDL-cholesterol and apo A-I. VFA was positively correlated with the TC, TG, apo B and E levels. There was a negative correlation between BMI and HDL2-cholesterol. VFA had significant positive correlations with TC and TG contents of the apo B-containing lipoproteins, including VLDL, IDL, and LDL, and a negative correlation with HDL2 cholesterol. SFA had no significant correlation with any variables. Table 6 shows the simple and partial correlation coefficients between the clinical and metabolic variables and LDL particle size (arbitrary units) in the subjects. Although LDL particle size had negative correlations with VFA, total cholesterol, triglyceride, and apo B and E levels, no correlations remained significant in the partial correlation analyses.
Discussion
This study has clarified that visceral fat accumulation is strongly associated with insulin resistance and the extent and severity of coronary artery lesions in non-obese male patients with CAD. We have also demonstrated that visceral fat accumulation is closely correlated with the increase in apo B-containing lipoproteins and small-sized LDL in middle-aged non-obese men. Several recent studies have indicated that insulin resistance closely relates to a cluster of multiple risk factors, [2] [3] [4] [5] such as hypertension, 27, 28 glucose intorelance 29 and dyslipidemia, [30] [31] [32] leading to the development of atherosclerotic disease. 33 Ferrannini et al have reported that whole body glucose uptake during a hyperinsulinemic -euglycemic clamp reduced by 30-40% in lean hypertensive subjects compared with normotensive controls. 34 Reaven et al demonstrated that both insulin resistance and insulin secretion are the determinants of the plasma glucose response to oral glucose load in individuals with a normal glucose tolerance. 29 In Study 1, SSPG concentration, FIRI, HOMA-IR, and PIA obtained by OGTT were significantly correlated with VFA in non-obese subjects with CAD, which suggests that there is a close relationship between visceral fat accumulation and insulin sensitivity and that the increase in visceral fat is closely related to the progression of insulin resistance in subjects with CAD. The basis of insulin resistance and the role of insulin resistance in this cluster of multiple risk factors have not yet been fully elucidated. Visceral fat is metabolically active, releasing free fatty acids (FFAs) into portal circulation, which go directly to the liver where the excess FFAs may impair hepatic insulin sensitivity and clearance resulting in peripheral hyperinsulinemia and insulin resistance. 35, 36 These observations indicate that visceral fat accumulation may be the basic and etiologic abnormality causing insulin resistance in the cluster of multiple risk factors.
We showed the VFA was independently correlated with the CAI, whereas FIRI, FPG, HOMA-IR and PGA obtained by OGTT had simple correlations with the index, which is concordant with the findings reported by Zamboni et al. 37 Young et al reported that the SSPG concentration in subjects with CAD was higher than that in control subjects, 38 but we did not find a significant correlation between the SSPG concentration and the CAI in subjects with CAD, which suggests that visceral fat accumulation is a stronger predictor of the development of CAD than insulin resistance in non-obese male subjects. Recent advances in the molecular biology of adipocytes have demonstrated that bioactive molecules derived from adipocytes, so-called 'adipocytokines', may be involved in the obesity-related disorders, and our recent studies revealed that plasminogen activator inhibitor type 1 and adiponectin secreted from visceral adipocytes may be directly related to the occurrence of atherosclerotic diseases. 39, 40 Consequently, visceral fat accumulation may be a more potent predictor for CAD than insulin resistance, although we did not measure the SSPG concentrations in the control subjects, and therefore, could not compare the degree of insulin sensitivity between the subjects with and without CAD. Further studies are necessary to clarify this relationship.
In Study 2, we demonstrated that the major characteristics associated with visceral fat accumulation in non-obese men were an increase in VLDL and small-sized LDL and a decrease in HDL. Després et al have previously reported that the same lipoprotein abnormalities were found in visceral fat obesity, 41 and numerous previous studies have shown that similar lipoprotein profiles were observed in patients with hyperapobetalipoproteinemia or with familial combined hyperlipidemia, which are common atherogenic lipid disorders. [42] [43] [44] [45] The metabolic basis of these disorders has not yet been clarified, although recent studies have proposed that one of the main metabolic defects of familial combined hyperlipidemia may be dysfunction of the gene influencing the turnover of FFAs located in fat tissue. 46, 47 We speculate that visceral fat accumulation might be a major contributor to the lipoprotein disorders of hyperapobetalipoproteinemia and familial combined hyperlipidemia. As mentioned before, visceral fat is metabolically very active, releasing FFAs into the portal circulation where they go directly to the liver and the excess FFAs may enhance the lipid synthesis in the liver. [48] [49] [50] [51] Recently we revealed that in an experimental animal model, excessive FFAs in the portal circulation up-regulate the gene expression of several lipid synthesis-related proteins, such as acyl-CoA synthetase and microsomal triglyceride transfer protein in the liver, resulting in an increase in the serum TG concentration. 52 Riches et al also showed that the reduction of visceral fat is associated with a decrease in the hepatic secretion of VLDL -apo B in human subjects. 53 Consequently, fat tissue, especially visceral fat tissue, may play a central role in the etiology of these lipoprotein abnormalities. These data and the findings of the present study indicate visceral fat accumulation may directly influence VLDL synthesis, thereby increasing serum apo-B-containing lipoproteins in non-obese men.
In the present study VFA was negatively correlated with LDL particle size, and it has been reported that serum TG, VLDL and HDL2 play an important role in the appearance of small-sized LDLs. 54, 55 Moreover, Reaven et al have also clarified that in a partial correlation analysis serum TG concentration is an independent predictor of LDL particle diameter. 56 Recently, Tchernof et al reported that concomitant high serum TG and low HDL-cholesterol levels produced the small-sized LDL particles in their subjects, including those with obesity. 57 They also showed that the influence of visceral fat accumulation on LDL particle size was comparably lower than that of these lipoprotein profiles. In the present study, the serum TC, TG, apo B and E concentrations were significantly correlated with LDL particle size, but these correlations, including that between VFA and LDL particle size, did not persist in the partial correlation analysis. We also demonstrated that VFA was closely related to serum TC, TG, apo B and E levels, and visceral fat accumulation directly associated with the increase in serum TG and VLDL levels. These data suggest that the close interaction of VFA and the other lipoproteinrelated factors may induce a lack of independent correlations between these factors and LDL particle size. Moreover, we observed that serum apo E and IDL levels were positively correlated with VFA in these subjects. It is well known that an increase in remnant lipoprotein contributes to the development of atherosclerosis. [58] [59] [60] Several recent studies also demonstrated that visceral fat accumulation is an important factor involved in the deterioration of post-prandial lipemia leading to an increase of remnant lipoprotein. 61, 62 This lipoprotein disorder may be one of the important atherogenic characteristics associated with visceral fat accumulation, but requires further evaluation.
In conclusion, visceral fat accumulation is closely related to insulin resistance, a smaller LDL particle size and consequently, leads to the cluster of multiple risk factors and the development of CAD in non-obese male subjects. Thus, visceral fat accumulation is a common and major risk factor for CAD in non-obese middle-aged Japanese men.
